24^th Annual Pathology Congress

Translational Pathology and Biomarkers

Translational Pathology and Biomarkers play a critical role in bridging basic research and clinical application, enabling personalized medicine and targeted therapy. This field focuses on identifying, validating, and applying predictive and diagnostic biomarkers to improve patient outcomes. By integrating molecular diagnostics, genomic profiling, and tissue-based analysis, translational pathology accelerates the transition from lab discoveries to clinical solutions. These biomarkers support early disease detection, prognosis, and real-time monitoring of treatment response. Advancements in precision pathology, immunohistochemistry, and bioinformatics are transforming healthcare delivery. Translational research in pathology drives innovation across oncology, neurology, and infectious diseases, enhancing diagnostic accuracy and therapeutic efficacy.